Leuprolide Acetate
Who holds supplier records for Leuprolide Acetate? 14 organisations hold a current record for Leuprolide Acetate: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4), China (2), Japan (1), South Korea (1) and 2 other countries (2); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Leuprolide Acetate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/leuprolide-acetate
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Leuprolide Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Takeda Pharmaceutical Company LimitedJapan Company GMP cert on recordActive DMF 11395, 9365, 10416 · latest filing Mar 1995
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 41260 · latest filing Feb 2025
- ALP PHARM BEIJING CO LTDActive DMF 34847 · latest filing Apr 2020
- ANYGEN CO LTDSouth KoreaActive DMF 25878 · latest filing Dec 2011
- AURO PEPTIDES LTDActive DMF 31170 · latest filing Nov 2016
- BACHEM AGCompany GMP cert on recordActive DMF 13822 · latest filing Nov 1998
- CHEMI SPAItaly Company GMP cert on recordActive DMF 14763 · latest filing Mar 2000
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 32295 · latest filing Dec 2017
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 25128 · latest filing Jun 2011
- PolyPeptide Laboratories (Sweden) ABSweden Company GMP cert on recordActive DMF 26832 · latest filing Feb 2013
- REALI TIDE BIOLOGICAL TECHNOLOGY (WEIHAI) CO LTDChinaActive DMF 33765 · latest filing Aug 2019
- SHANXI TONGDA PHARMACEUTICAL CO LTDActive DMF 40556 · latest filing Sept 2024
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 27832 · latest filing Jan 2014
- ZHEJIANG PEPTITES BIOTECH CO LTDChinaActive DMF 35071 · latest filing Sept 2020
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (6)
Organisations whose Type II DMFs for Leuprolide Acetate are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- China · Inactive DMF 29355 · filed Apr 2015
- United States · Inactive DMF 12052, 24845 · filed May 2013
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 15189 · filed Dec 2000
- LIPOTEC SAInactive DMF 15164 · filed Nov 2000
- United States · Inactive DMF 14440 · filed Oct 1999
- BACHEM AMERICAS INCInactive DMF 11236 · filed Dec 1994
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Leuprolide acetate is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH) used in the treatment of hormone-responsive cancers such as prostate cancer and conditions like endometriosis. It acts by temporarily suppressing the production of certain hormones.
Chemical identity
- IUPAC name
- acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
- Canonical SMILES
- CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O
- InChIKey
- RGLRXNKKBLIBQS-XNHQSDQCSA-N
- Synonyms
- Lupron API, a-43818, abbott-43818, carcinil, eligard, enantone, fensolvi, leuplin, leuporelin acetate, leuprolide monoacetate, leuprorelin acetate, lucrin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Gonadotropin Releasing Hormone Receptor Agonist
- Mechanism of action
- Gonadotropin Releasing Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Leuprolide Acetate?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Leuprolide Acetate: Takeda Pharmaceutical Company Limited (Japan), Alembic Pharmaceuticals Limited (India), ALP PHARM BEIJING CO LTD, ANYGEN CO LTD (South Korea), AURO PEPTIDES LTD, BACHEM AG, CHEMI SPA (Italy) and MATRIX PHARMACORP PRIVATE LTD (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Leuprolide Acetate Drug Master Files are active?
Takeda Pharmaceutical Company Limited (DMF 11395, 9365), Alembic Pharmaceuticals Limited (DMF 41260), ALP PHARM BEIJING CO LTD (DMF 34847), ANYGEN CO LTD (DMF 25878), AURO PEPTIDES LTD (DMF 31170), BACHEM AG (DMF 13822), CHEMI SPA (DMF 14763) and MATRIX PHARMACORP PRIVATE LTD (DMF 32295) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Leuprolide Acetate records mean?
6 organisations have only inactive Type II DMFs for Leuprolide Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Leuprolide Acetate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Leuprolide Acetate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.